Argent Biopharma Issues New Equity Securities
Company Announcements

Argent Biopharma Issues New Equity Securities

Argent Biopharma (AU:RGT) has released an update.

Argent Biopharma Limited has announced the issuance of 600,000 unquoted equity securities under the performance rights category. These securities are scheduled for issue on October 15, 2024. This move could indicate potential growth opportunities for the company and may interest investors in the biopharmaceutical sector.

For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskArgent BioPharma’s Strategic Moves and Collaboration
TipRanks Australian Auto-Generated NewsdeskArgent BioPharma Issues New Shares Amidst Strategic Growth
TipRanks Australian Auto-Generated NewsdeskArgent Biopharma Lists New Shares on ASX
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App